FDA Inspection 1018375 — Emergent BioSolutions Canada Inc.

Emergent BioSolutions Canada Inc. — FEI 3003153579

The FDA completed an inspection of Emergent BioSolutions Canada Inc. on May 16, 2017 in Winnipeg. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 16, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Winnipeg (Canada)